Finasteride Side Effects. What The Trial Evidence Actually Shows
Finasteride is the most effective single medication for male pattern hair loss and it carries a small but real excess risk of sexual side effects. In the pivotal 1-year trials, sexual adverse events occurred in 3.8% of men taking finasteride against 2.1% on placebo. In 2025 the European Medicines Agency added a warning about suicidal ideation to the label. Both facts are true, and you deserve them stated plainly rather than argued away or amplified.
Key points
In the pivotal trials, sexual adverse events were reported by 3.8% of men on finasteride against 2.1% on placebo, an excess of roughly 1.7 percentage points.
A meta-analysis of 15 randomised, double-blind, placebo-controlled trials found a relative risk of sexual dysfunction of 1.66 compared with placebo, with a confidence interval of 1.20 to 2.30.
In the 4-year PLESS trial of 3,040 men, drug-related sexual events were raised in year 1 at 15% against 7% on placebo, with no difference between groups in years 2 to 4.
In 2025 the European Medicines Agency added a suicidal ideation warning to the finasteride label and required a patient information card with every EU prescription.
Weighing finasteride against the alternatives? Message a GMC-registered doctor on WhatsApp or email team@thewellnesslondon.com.
What finasteride does, and how well
Finasteride blocks the enzyme that converts testosterone into dihydrotestosterone, the androgen that progressively shrinks genetically sensitive scalp follicles. Lowering DHT slows or halts that process.
It is the most effective single medication available for male pattern hair loss, with roughly 80 to 90% of men stabilising or regrowing hair over 12 months of use, and a 2025 meta-analysis in Frontiers in Medicine reconfirmed that finasteride combined with minoxidil remains the strongest standard combination, outperforming either drug alone.
That efficacy is the context for everything below. A decision about side effects is only useful alongside a clear view of what you would be giving up.
The sexual side effect numbers
During treatment
The figures most often quoted come from the pivotal trials in male pattern hair loss. Sexual adverse events were reported by 3.8% of men taking finasteride 1mg against 2.1% on placebo, and pooled 1-year data put any sexual adverse event at roughly 4.2% against 2.2%. The difference attributable to the drug is therefore on the order of 2 percentage points across all categories combined, and smaller within any single category.
A systematic review and meta-analysis of 15 randomised, double-blind, placebo-controlled trials found a relative risk of sexual dysfunction of 1.66 versus placebo, with a confidence interval of 1.20 to 2.30. A 2020 meta-analysis of 34 studies found that 5-alpha-reductase inhibitors carried a 1.87-fold risk of the cluster of adverse effects sometimes described as post-finasteride syndrome during the trial period.
Whether they persist
This is the part that dominates online discussion and where the evidence is least settled.
In the 4-year PLESS trial of 3,040 men, drug-related sexual events were more common on finasteride during year 1, at 15% against 7%, with no difference between the groups in years 2 to 4. A 2017 retrospective cohort of 4,284 men taking low-dose finasteride found persistent sexual symptoms in 0.8% at a median of 4 years after stopping, and of the men who experienced symptoms during treatment, around a third reported that they persisted.
Against that, other work has found that among men who stopped because of sexual dysfunction, persistence was actually greater in the placebo group, which argues against the drug being responsible in those cases.
The honest summary is that persistent symptoms after stopping are reported, are acknowledged in prescribing information, and remain poorly understood in terms of how often they occur and why some men are affected.
Want this discussed against your own situation? Ask our doctors on WhatsApp.
The 2025 regulatory change
In 2025 the European Medicines Agency added a warning about suicidal ideation to the finasteride label and introduced a requirement for a patient information card to accompany every prescription in the EU. That is a significant regulatory action and it should be part of any informed discussion.
There is a plausible mechanism. Finasteride crosses the blood-brain barrier and reduces production of allopregnanolone, a neurosteroid involved in mood and anxiety regulation, which offers a biological explanation for neuropsychiatric effects in susceptible individuals.
What this does not mean is that finasteride causes depression in most men who take it. It means the risk is now formally recognised, that anyone starting it should be told, and that any change in mood while taking it should be reported to your doctor rather than dismissed.
Two things worth knowing about the alternatives
Topical finasteride is not automatically safer
One randomised comparison reported treatment-related sexual adverse events in 2.8% of the topical group, 3.3% of the placebo group and 4.8% of the oral finasteride group, which is a reasonable signal that systemic exposure is lower.
It is not, however, zero. Finasteride is absorbed through the skin into the bloodstream, and in April 2025 the US Food and Drug Administration issued a specific warning about compounded topical finasteride, reporting 32 adverse event reports between 2019 and 2024. Most topical finasteride is compounded rather than a standardised licensed product, so formulations vary.
The nocebo effect is real and measurable
In one study, men counselled in advance about the possibility of sexual side effects reported them at a substantially higher rate than men who were not counselled. That does not mean the side effects are imaginary. It means expectation influences reporting, which is worth knowing when you read forum accounts, and it is an argument for accurate information rather than for withholding it.
If you decide against finasteride
This is a reasonable decision and plenty of men make it, particularly those on testosterone therapy for whom lowering DHT is the opposite of what they are trying to achieve.
The main hormone-free options are topical minoxidil, which works on the growth cycle and blood supply rather than hormones, and PRP, which uses growth factors concentrated from your own blood and has no hormonal action at all. PRP is supported by a 2025 meta-analysis in Dermatology and Therapy pooling 43 randomised controlled trials and 1,877 participants which found it increases hair density, and pooled data show PRP combined with minoxidil outperforms either alone.
The honest trade-off is that a plan without a DHT blocker is working against an ongoing hormonal pressure you have chosen not to reduce, so consistency and maintenance matter more. For many men that is an acceptable exchange, and it is their decision to make with the numbers in front of them.
Want a hormone-free plan? Message us on WhatsApp.
What treatment costs in London
Finasteride is inexpensive, whether prescribed privately or through an online service. Flagship Harley Street and Mayfair clinics commonly charge £600 to £850 or more per PRP session, and London practices generally charge 50 to 70 percent more than clinics outside the capital.
Our care is doctor-led and priced below those rates, with the figure for your plan confirmed after your free suitability review, and blood testing run from the same clinic.
The suitability review
Every enquiry begins with a free doctor-led suitability review rather than a booking. A GMC-registered doctor assesses your scalp with dermoscopy, reviews or arranges your bloods, and discusses the medication question properly rather than defaulting either way.
You then get one of two answers. Approved for treatment, with the options set out honestly including where finasteride would be the more effective choice and where a hormone-free plan is reasonable. Or not approved, which sometimes means a deficiency to correct first, or follicles that have already closed.
We neither push finasteride nor dismiss it. It is the most effective medication available and it carries a small excess risk, and which way that balance falls is yours to decide.
Why people choose The London PRP Clinic by The Wellness
The London PRP Clinic by The Wellness is a doctor-led, blood-test-first clinic treating from 10 Portman Square in Marylebone and the Light Centre in Belgravia. Every treatment is performed by GMC-registered doctors, and no clinician treats a patient here until they have completed 100 supervised treatments.
Across our work we report an 87 percent patient success rate, a 32 percent average density increase in hair restoration and more than 187 five-star reviews.
Book your free suitability review. Message us on WhatsApp, email team@thewellnesslondon.com, or call +44 20 3951 3429.
Frequently asked questions about finasteride side effects
How common are finasteride side effects?
In the pivotal trials, sexual adverse events occurred in 3.8% of men on finasteride against 2.1% on placebo, an excess of roughly 1.7 percentage points. A meta-analysis of 15 placebo-controlled trials found a relative risk of 1.66.
Do finasteride side effects go away?
Most resolve either on stopping or, in many cases, while continuing the medication. In the 4-year PLESS trial the excess was confined to year 1, with no difference between groups in years 2 to 4.
Is post-finasteride syndrome real?
Persistent symptoms after stopping are reported and acknowledged in prescribing information. One cohort of 4,284 men found persistent sexual symptoms in 0.8% at a median of 4 years after stopping. How often it occurs and why remain poorly understood.
What did the EMA change in 2025?
The European Medicines Agency added a warning about suicidal ideation to the finasteride label and required a patient information card with every EU prescription.
Is topical finasteride safer?
Systemic exposure appears lower, with one trial reporting sexual adverse events in 2.8% of the topical group against 4.8% on oral. It is not risk-free, and the FDA issued a warning about compounded topical finasteride in April 2025.
What are the alternatives if I do not want finasteride?
Topical minoxidil and PRP, neither of which has a hormonal action. PRP is supported by a 2025 meta-analysis of 43 randomised trials and 1,877 participants, and works best alongside minoxidil.
This article is for information and does not replace personal medical advice. Decisions about finasteride should be made with a doctor who knows your history. If you experience mood changes while taking finasteride, speak to your doctor. All treatments at The London PRP Clinic by The Wellness are performed by GMC-registered doctors. Written and reviewed by the clinical team at The Wellness. Last updated September 2026.